Please note that only limited free access to this journal is available in your country or territory.

To access the full content of this article you must purchase it (US$9.49). After payment of this one-off fee, you will gain unrestricted online access to the article and a PDF version sent to your email.

As part of our special introductory offer, after purchasing this article you will have unrestricted access to all the articles in this issue for free!

Registered users can purchase/access the article by logging in below. To register for free click here

Registered users login here:

  • Email Address:
     
  • Password:
     
  •  
If you have forgotten your password click here
1 ratings / 3 average

Miscellaneous

Gabay C, Bel M, Combescure C et al.

University Hospitals of Geneva and University of Geneva, Geneva, Switzerland.

 Arthritis Rheum 2011;63:1486–96.

Editor’s note: Prevention of influenza in immunocompromised patients is vital in preventing the occurrence of severe respiratory complications during community outbreaks. Previous studies have suggested that vaccine responses may be attenuated in patients on immunosuppressive therapies. Oil-in-water squalene-based adjuvanted influenza vaccines are now licensed in Europe. In Switzerland, these vaccines are recommended as a split-dose schedule for immunocompromised patients and as a single dose for healthy individuals.

Please login or register to continue reading this article
Return to top
Login/Register

Post Page On

LATEST ARTICLES

Our most popular articles